mFlusiva becomes the first mRNA influenza vaccine approved by the FDA
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.